Apple v Masimo
US Judge Rules Against Apple In Masimo Pulse Oximeter Patent Case
Apple smartwatches could face an import ban after a U.S. judge ruled that the company infringed on one of Masimo's pulse oximeter patents.
Apple to halt some Apple Watch Sales in US
Apple is planning to stop selling some versions of the Apple Watch in the United States as soon as this week to get ahead of what could be one of the most momentous patent disputes in years.
Biden administration upholds Apple Watch ban
US president Joe Biden's administration on Tuesday opted not to veto a government tribunal's ruling to ban imports of Apple Watches.
Apple files emergency motion against Apple Watch ban
Apple filed an emergency motion with a U.S. appeals court to pause a ban on importing and selling some of its Apple Watch models.
U.S. Appeals Court temporarily stops Apple Watch Sales Ban
Apple will be able to sell the latest Apple Watches after an import ban was temporarily stopped by a U.S. appeals court on Wednesday.
Apple Resumes Watch Series 9 and Ultra 2 Sales in U.S.
Apple has started resuming sales of its Apple Watch Series 9 and Ultra 2 in the country.
Apple to Remove Blood-Oxygen Tool From Apple Watches
Apple is planning to remove its blood-oxygen feature from the Apple Watch Series 9 and Apple Watch Ultra 2, to circumvent a US ban of the devices.
Apple Watches Banned again in U.S.
From Jan. 18, Apple will again be banned from selling Apple Watch Series 9 and Ultra 2 devices in the US due to its ongoing patent infringement case with Masimo.
Apple iOS 18.6.1 restores blood oxygen monitoring in the United States
Apple has released iOS 18.6.1 for U.S. iPhones only, bringing a Blood Oxygen monitoring update.
Apple watchOS 11.6.1 restores blood oxygen monitoring in the United States
Apple has released watchOS 11.6.1 in tandem with iOS 18.6.1 bringing a Blood Oxygen monitoring update in the United States.
Masimo sues US Customs over Apple Watch Blood Oxygen feature
Masimo has filed a lawsuit against U.S. Customs and Border Protection (CBP) over the reactivation of the Apple Watch’s Blood Oxygen feature.
US Customs asks court to dismiss Masimo case
Masimo recently filed a lawsuit against U.S. Customs and Border Protection, accusing the agency of improperly allowing Apple to resume selling Apple Watches with the Blood Oxygen feature activated.
US Jury orders Apple to pay Masimo $634M in never ending patent fight
A federal jury in California has found that Apple infringed on a Masimo patent for its pulse oximetry technology and awarded Masimo $634 million in damages.
Apple Watch Blood Oxygen Workaround Doesn’t Infringe on Masimo Patents
U.S. International Trade Commission (ITC) judge has determined that Apple’s current methods of leveraging blood oxygen sensing on Apple Watch do not infringe on Masimo’s patents
Apple filed an emergency motion with a U.S. appeals court to pause a ban on importing and selling some of its Apple Watch models.
The company requested a pause until January 12 pending a U.S. customs decision on whether a redesigned version of the devices falls outside the scope of the International Trade Commission’s remedial orders.
The importation and sale of some Apple Watch models was banned effective today after the Biden administration declined to veto a decision by the International Trade Commission.
Apple can still appeal the ban to the U.S. Court of Appeals for the Federal Circuit, and the watches can still be sold by third parties
Apple has routinely marketed its smartwatch as a life-saving device, which has helped launch the Apple Watch into the stratosphere, making it the most popular watch sold around the world. But its skirmish with Masimo threatens to undermine that.
In October, the US International Trade Commission ruled that Apple was in violation of Masimo’s pulse oximeter patent, which uses light-based technology to read blood-oxygen levels. President Biden has 60 days to review the ruling before a ban could go into effect.
Apple launched its Series 9 phone in September. It features a custom S9 chip for faster processing and enables hand gestures to control the watch, thanks in part to an enhanced neural engine that processes data from sensors and machine learning.
Apple said it firmly believes the ITC’s findings are inaccurate and should be reversed. It also plans to take the decision to the Federal Circuit.
In addition, Apple said it has submitted evidence demonstrating how a ban would negatively impact healthcare, scientific and medical research, and Apple Watch users who rely on the ECG, blood oxygen and other health-related features.
